Keywords

Details

Category:

Articles

Type:

artykuł w czasopiśmie wyróżnionym w JCR

Published in:

Journal of Inclusion Phenomena and Macrocyclic Chemistry no. 93, pages 77 - 83,
ISSN: 1388-3127

Language:

English

Publication year:

2019

Bibliographic description:

Majdecki M., Krzak A., Sadowska K., Swiech O.: Monosubstituted hydrazone β-cyclodextrin derivatives for pH-sensitive complex formation with aromatic drugs// JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY. -Vol. 93, iss. 1-2 (2019), s.77-83

DOI:

Digital Object Identifier (open in new tab) 10.1007/s10847-018-0841-x

Bibliography: test

1. Ueno, A., Breslow, R.: Selective sulfonation of a secondary hydroxyl group of β-cyclodextrin. Tetrahedron Lett. 23, 3451- 3454 (1982) open in new tab
2. Tripodo, G., Wischke, C., Neffe, A.T., Lendlein, A.: Efficient synthesis of pure monotosylated betacyclodextrin and its dimers. Carbohydr. Res. 381, 59-63 (2013) open in new tab
3. Yoon, J., Hong, S., Martin, K.A., Czarnik, A.W.: A general method for the synthesis of cyclodextrinyl aldehydes and carbox- ylic acids. J. Org. Chem. 60, 2792-2795 (1996) open in new tab
4. Huff, J.B., Bieniarz, C.: Synthesis and reactivity of 6-β-cyclodextrin monoaldehyde: an electrophilic cyclodextrin for the derivatization of macromolecules under mild conditions. J. Org. Chem. 59, 7511-7516 (1994) open in new tab
5. Cornwell, M.J., Huff, J.B., Bieniarz, C.: A one-step synthesis of cyclodextrin monoaldehydes. Tetrahedron Lett. 36, 8371-8374 (1995) open in new tab
6. Dess, D.B., Martin, J.C.: Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones. J. Org. Chem. 48, 4155-4156 (1983) open in new tab
7. Dess, D.B., Martin, J.C.: A useful 12-I-5 triacetoxyperiodinane (the Dess-Martin periodinane) for the selective oxidation of pri- mary or secondary alcohols and a variety of related 12-I-5 species. J. Am. Chem. 113, 7277-7287 (1991) open in new tab
8. Swiech, O., Mieczkowska, A., Chmurski, K., Bilewicz, R.: Inter- molecular interactions between doxorubicin and β-cyclodextrin 4-methoxyphenol conjugates. J. Phys. Chem. B 116, 1765-1771 (2012) open in new tab
9. Swiech, O., Majdecki, M., Dembinski, A., Krzak, A., Stepkowski, T., Wojciuk, G., Kruszewski, M., Bilewicz, R.: Competition between self-inclusion and drug binding explains the pH depend- ence of the cyclodextrin drug carrier-molecular modeling and electrochemistry studies. Nanoscale 8, 16733-16742 (2016) open in new tab
10. Krohn, K., Eds: Molecular mechanisms of anthracycline activity. In: Anthrcycline Chemistry and Biology, Mode of Action, Clinical Aspects and New Drugs, pp. 5-11, Springer, Berlin (2008) open in new tab
11. Chaires, J.B., Herrera, J.E., Waring, M.J.: Preferential binding of daunomycin to 5′TACG and 5′TAGC sequences revealed by footprinting titration experiments. Biochemistry 29, 6145-6153 (1990) open in new tab
12. Quigley, G.J., Wang, A.H., Ughetto, G., van der Marel, G., van Boom, J.H., Rich, A.: Molecular structure of an anticancer drug- DNA complex: daunomycin plus d(CpGpTpApCpG). Proc. Natl. Acad. Sci. USA 77, 7204-7208 (1980) open in new tab
13. Takemura, G., Fujiwara, H.: Doxorubicin-induced cardiomyo- pathy from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 49, 330-352 (2007) open in new tab
14. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., Gianni, L.: Anthracyclines: molecular advances and pharmacologic develop- ments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185-229 (2004) open in new tab
15. Myers, C.E., McGuire, W., Young, R.: Adriamycin: amelioration of toxicity by alpha-tocopherol. Cancer Treat. Rep. 60, 961-962 (1976) open in new tab
16. Bekers, O., Kettenes, J.J., Van Helden, S.P., Seijkens, D., Beijnen, J.H., Bulti, A., Underberg, W.J.: Inclusion complex formation of anthracycline antibiotics with cyclodextrins; a proton nuclear magnetic resonance and molecular modelling study. J. Incl. Phe- nom. Mol. Recogn. Chem. 11, 185-193 (1991) open in new tab
17. Husain, N., Ndou, T.T., De La Peña, A.M., Warner, I.M.: Com- plexation of doxorubicin with β and γ-cyclodextrins. Appl. Spec- trosc. 46, 652-658 (1992) open in new tab
18. Frömming, K.-H., Szejtli, J.: Cyclodextrins in Pharmacy. Kluwer Acad. Publ., Dordrecht (1994) open in new tab
19. Duchêne, D.: New Trends in Cyclodextrins and Derivatives. Edi- tions de Sante, Paris (1991)
20. Szejtli, J.: Cyclodextrin Technology. Kluwer Acad. Publ., Dordrecht (1988) open in new tab
21. Duchêne, D.: Cyclodextrins and their Industrial Uses. Editions de Sante´, Paris (1987) open in new tab
22. Loftsson, T.: The effects of cyclodextrins on the chemical stability of drugs in aqueous solutions. Drug Stab. 1, 22-33 (1995)
23. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996) open in new tab
24. Brewster, M.E., Loftsson, T., Estes, K.S., Lin, J.L., Friđriksdóttir, H.: Effects of various cyclodextrins on solution stability and dis- solution rate of doxorubicin hydrochloride. Int. J. Pharm. 79, 289-299 (1992) open in new tab
25. Al-Ghorbani, M., Vigneshwaran, V., Ranganatha, V.L., Prabhakar, B.T., Shaukath, A.K.: Synthesis of oxadiazole-morpholine deriva- tives and manifestation of therepressed CD31 Microvessel Density (MVD) as tumoral angiogenic parameters in Dalton's Lymphoma. Bioorg. Chem. 60, 136-146 (2015) open in new tab
26. Mora, L., Chumbimuni-Torres, K.Y., Clawson, C., Hernandez, L., Zhang, L., Wang, J.: Real-time electrochemical monitoring of drug release from therapeutic nanoparticles. J. Controlled Release 140, 69; (2009) open in new tab
27. Osa, T., Matsue, T., Fujihira, T.: Heterocycles 6, 1833-1839 (1977) open in new tab
28. Swiech, O., Dutkiewicz, P., Wojciuk, K., Chmurski, K., Krusze- wski, M., Bilewicz, R.: Cyclodextrin derivatives conjugated with aromatic moieties as pH-responsive drug carriers for anthracy- cline. J. Phys. Chem. B 117, 13444-13450 (2013) open in new tab

show (28) hide

Verified by:

Gdańsk University of Technology